Availability of and challenges to resistance testing for second-line drugs, including the new and repurposed TB drugs

The Union
Europe/Paris GMT+2

Description

The session will report on the survey of Union members and members of Global Drug Initiative (GDI) and Global Laboratory Initiative (GLI) about the availability of drug susceptibility testing (DST), followed by a discussion of potential strategies to expand this availability.

Facilitator: Dr Alaine Umubyeyi Nyaruhirira, Management Sciences for Health, South Africa

Speakers:

Topic 1: Results of the 2020 DR-TB WG/GDI/GLI Survey, Dr Robert Horsburgh, Boston University, USA

Topic 2: Availability of and challenges to resistance testing for second-line drugs; a laboratory perspective, Dr Daniela Cirillo, Milan Supranational Reference Laboratory, Italy

Response: Availability of and challenges to resistance testing for second-line drugs; a programmatic perspective, Dr Fraser Wares, KNCV, The Netherlands

Alaine Umubyeyi Nyaruhirira

Results of the 2020 DR-TB WG/GDI/GLI Survey, Availability of and challenges to resistance testing for second-line drugs; a laboratory perspective, Response: Availability of and challenges to resistance testing for second-line drugs; a programmatic perspective

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Robert Horsburgh, Daniela Cirillo, Fraser Wares

 

Link to the Event

Banner to the Event

Availability of and challenges to resistance testing for second-line drugs, including the new and repurposed TB drugs
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"